Evidence map›Paper›PMID 42694739›Full record

ReviewFrontiers in oncology2026

Visualization-driven digital technologies in oncology: current applications, technological advances, and future directions.

Xiaoxia Duan, Yuxin Guo, Yanyan Yu, Sheng Li, Yujie Sun

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaoxia DuanCollege of Future Technology, Peking University, Beijing, China.
Yuxin GuoBeijing Zestbridge Media Technology Co., Ltd., Beijing, China.
Yanyan YuBeijing Zestbridge Media Technology Co., Ltd., Beijing, China.
Sheng LiBeijing Zestbridge Media Technology Co., Ltd., Beijing, China.
Yujie SunCollege of Future Technology, Peking University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise anatomical understanding and spatial cognition are fundamental to effective oncologic management. While traditional two-dimensional imaging serves as the diagnostic standard, it often lacks the intuitive depth required for complex decision-making. This review synthesizes the role of visualization-driven digital technologies in oncology-including AI-driven 3D reconstruction, augmented reality (AR), multimodal fusion, radiomics, and digital twins-as cognitive interfaces across the entire continuum of cancer care. We comprehensively review current applications, ranging from deep learning-enhanced early screening and segmentation in pre-treatment planning to AR-guided surgical navigation and adaptive radiotherapy during treatment. Furthermore, we highlight the emerging utility of radiomics in post-treatment surveillance and the humanistic value of immersive visualization in patient education for anxiety reduction. Despite these advancements, clinical integration remains impeded by challenges related to intraoperative precision stability, economic feasibility in resource-limited settings, and data privacy risks associated with biometric re-identification. Looking ahead, we propose that the future of oncologic visualization lies in the convergence of physics-informed deep learning for dynamic motion correction, cloud-based edge computing for cost democratization, and privacy-preserving collaborative learning strategies. Current advances in visualization technologies support the transition from passive anatomical viewing toward more interactive, data-driven clinical decision support, though the integration of these approaches into comprehensive predictive models requires further prospective validation.

Indexed as

artificial intelligenceaugmented realitydigital twinoncologyvisualization-driven digital technologies

Identifiers

PMID42694739
PMCPMC13539506

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.